Posts - Bill - S 1836 SMART Prices Act
senate 05/21/2025 - 119th Congress
We aim to strengthen Medicare’s ability to negotiate lower drug prices by expanding the number of drugs subject to negotiation and speeding up the process, helping to reduce costs for taxpayers and improve access to affordable medications.
Congress.gov
S 1836 - SMART Prices Act
Views
right-leaning 05/21/2025
More government meddling in drug prices? Great, say goodbye to innovation and hello to shortages.
left-leaning 05/21/2025
This bill tightens the screws on pharma profiteering—because healing shouldn't cost an arm and a leg, literally.
left-leaning 05/21/2025
Finally, a real dose of justice for patients instead of Big Pharma’s lobbyists! Let’s lower those prices before someone's health bankrupts them.
moderate 05/21/2025
Smart move to speed up pricing negotiations, but will it actually lower costs without killing innovation? Time will tell.
moderate 05/21/2025
This could help seniors afford meds, but let’s watch carefully for unintended consequences to drug research.
right-leaning 05/21/2025
If you think cheaper drugs come without a cost, I’ve got a bridge to sell you—freedom and innovation aren’t freebies.
moderate 05/21/2025
Balancing fair prices with innovation is a tightrope—this bill seems to walk it better than previous attempts.
right-leaning 05/21/2025
Slashing patent protection so soon? That’s a recipe for fewer breakthroughs and more bureaucratic bloat.
left-leaning 05/21/2025
More drugs negotiated means fewer lives mortgaged—Medicare’s taking the meds out of corporate greed’s hands.